Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Published in the Commonwealth of Australia Gazette No. GN 32, 13 August 2003
Therapeutic Goods Act 1989
I, TERRY SLATER, National Manager, Therapeutic Goods Administration, delegate of the Parliamentary Secretary to the Minister for Health and Ageing, under subsection 17 (5) of the Therapeutic Goods Act 1989, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods for listed goods:
- preparations, referred to in item 3 of Schedule 4, Part 1 of the Therapeutic Goods Regulations (the Regulations) that contain, as an ingredient, cold-pressed neem (Azadirachta indica) seed oil for topical application at concentrations up to 1%, and at concentrations greater than 1% when in a container fitted with a child resistant closure and labelled with the statements:
- "Not to be taken";
- "Keep out of reach of children"; and
- "Do not use if pregnant or likely to become pregnant."
- preparations, referred to in item 3 of Schedule 4, Part 1 of the Regulations that contain, as an ingredient, calcium sodium caseinate, and that are supplied with a label that includes a statement to the effect "contains cow's milk protein", which is to be mentioned in Division 3 of Part 5 of Schedule 4 of the Regulations.
Dated 4 August 2003
National Manager, Therapeutic Goods Administration
Delegate of the Parliamentary Secretary